Potomac Capital Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $363K | Buy |
149,585
+75,000
| +101% | +$182K | 0.42% | 41 |
|
|
2023
Q3 | $151K | Hold |
74,585
| – | – | 0.19% | 44 |
|
|
2023
Q2 | $220K | Sell |
74,585
-5,415
| -7% | -$16K | 0.23% | 50 |
|
|
2023
Q1 | $200K | Hold |
80,000
| – | – | 0.21% | 54 |
|
|
2022
Q4 | $254K | Buy |
+80,000
| New | +$254K | 0.3% | 48 |
|
|
2022
Q2 | – | Sell |
-40,000
| Closed | -$540K | – | 62 |
|
|
2022
Q1 | $540K | Hold |
40,000
| – | – | 0.47% | 45 |
|
|
2021
Q4 | $521K | Buy |
+40,000
| New | +$521K | 0.46% | 48 |
|